A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies
Part of paid clinical trials in La Jolla, California.
- Sponsor
- Kumquat Biosciences Inc.
- Study ID
- NCT07207707
- Phase
- PHASE1
- Status
- Recruiting
Conditions
- Solid Tumor Malignancies
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- KQB548 — DRUGOral KQB548
Study Details
The goal of this trial is to learn if KQB548 works to treat patients with advanced solid malignancies with a KRAS G12D mutation. It will also learn about the safety of KQB548. The main questions it aims to answer are: * What is the safe dose of KQB548? * Does KQB548 decrease the size of the tumor? * What happens to KQB548 in the body?
Key Dates
- Start date
- Sep 16, 2025
- Status verified
- Mar 2026
- Primary completion
- Sep 30, 2026
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 78 participants (estimated)
- Allocation
- NA
- Intervention model
- SEQUENTIAL
- Primary purpose
- TREATMENT
Arms
- Experimental: Monotherapy Dose Escalation
Primary Outcome Measure
Safety,Tolerability, MTD/MAD and/or RDE in the Study Population [ Time Frame: Up to 30 months ]
Central Contacts
- Kumquat Clinical Development858-214-2700
Locations (13)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, San Diego | La Jolla | California | 92037 | - |
| University of California, Los Angeles | Los Angeles | California | 90095 | - |
| SCRI - Denver | Denver | Colorado | 80218 | - |
| University of Miami - Sylvester Comprehensive Cancer Center | Miami | Florida | 33136 | - |
| START Midwest | Grand Rapids | Michigan | 49546 | - |
| The Christ Hospital | Cincinnati | Ohio | 45219 | - |
| NEXT Oncology - Austin | Austin | Texas | 78758 | - |
| MD Anderson Cancer Center | Houston | Texas | 77030 | - |
| NEXT Oncology - Dallas | Irving | Texas | 75039 | - |
| NEXT Oncology - San Antonio | San Antonio | Texas | 78229 | - |
| University of Utah - Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | - |
| NEXT Virginia | Fairfax | Virginia | 22031 | - |
| Fred Hutchison Cancer Center | Seattle | Washington | 98195 | - |
Find similar trials in La Jolla, CA
Related Studies
- A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain MetastasesPHASE1 · Recruiting · A2A Pharmaceuticals Inc. · Detroit, Michigan
- A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid MalignanciesPHASE1 · Recruiting · Kumquat Biosciences Inc. · Phoenix, Arizona
- Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid TumorsPHASE1 · Recruiting · Vir Biotechnology, Inc. · Scottsdale, Arizona
- A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid MalignanciesPHASE1 · Recruiting · Kumquat Biosciences Inc. · Phoenix, Arizona